Lu sur http://onlinelibrary.wiley.com/wol1/doi ... 2/abstract
Traduction disponible directement en cliquant en bas à droite de ce message sur notre forum
B-cell–activating factor is elevated in serum of patients with myasthenia gravis
Sa-Yoon Kang MD1,*, Chul-Hoo Kang MD1 andKeun-Hwa Lee PhD2
Version of Record online: 15 OCT 2016
DOI: 10.1002/mus.25162
ABSTRACT
- Introduction:
Myasthenia gravis (MG) is a B-cell–mediated autoimmune disease. B-cell–activating factor (BAFF) is a major factor in B-cell development and activation. In this study we investigated serum BAFF levels in MG patients.
- Methods:
We compared the serum BAFF levels of 20 MG patients with gender-matched healthy controls. We assayed serum concentrations of BAFF and anti-acetylcholine receptor antibody (AChR) titers.
- Results:
Serum BAFF levels of MG patients with AChR antibodies were significantly higher than those of healthy controls. A significant positive correlation was observed between serum BAFF levels and anti-AChR antibody titers. BAFF values did not correlate with disease severity.
- Conclusions:
BAFF may play a major role in the pathogenesis of MG, and it may provide a potential target for therapy in patients with MG.
Muscle Nerve, 2016
Article complet dans l’espace donateur
